Table G5Methodological quality—observational analytical studies

Cohort studies— NOS scaleCohort studies describing representative samples of the target population (n = 55) 80,439,449,453,456,466,469,479,487,492,501,520,522,548,550,555,563,605,607,612,619,624,776,803,874,921,970a624b142,161,422,428,655,669,675,695,708,835,855,861,877,935,949,950,958,969,972,994,997a950b973a741,755,760,792
Cohort studies describing nonexposed cohorts drawn from the same community as the exposed cohort (n = 56) 80,400,401,436,439,449,453,458,466,486,520,522,527,540,548,563,599,605,614,624,772,807,873,874,907,912,921a624b142,416,663,668,670,685,693,695,699,703,708,712,781,788,790,857,877,935,950,958,969a950b973a741,749,755,757,1003
Cohort studies that reported reliable methods for ascertainment of exposure (n = 10) 141,439,456,458,668,776,835,949,969,973a
Cohort studies that reported reliable methods for ascertainment of outcome (n = 10) 80,453,466,469,605,619,630,695,958,1009
Cohort studies that adjusted for important confounding factors in the design or analysis (n = 99) 105,142,200,201,385,399401,422,449,466,486,492,501,522,555,574,583,585,598,599,607,612,668,669,672,675,685,693,703,723,772,779,803,833,853,873,909,923,949,950,964,972,983,997a950b936,973a141,416,439,453,458,487,498,520,526,563,576,581,644,647,695,700,712,720,731,734,741,745,749,755,757,763,776,792,807,817,835,855,857,861,874,877,886,907,921,939,948,958,960,967,969,985,989,995,1003,1008,1009
Cohort studies that reported reliable methods for outcome assessment (n = 109) 80,161,200202,385,399401,416,428,439,449,450,452,456,458,466,479,486,498,499,501,508,520,526,540,555,576,581,585,586,598601,612,619,633,643,644,647,655,668,669,672,675,685,686,693,699,700,703,712,720,721,723,731,734,741,745,749,755,757,760,763,771,772,776,779,781,792,803,807,817,833,853,855,857,861,874,877,886,907,909,912,917,923,927,928,939,948,949,952,958,960,964,967,969,970,972,983,985,989,995,997,1003,1008,1009
Cohort studies reporting length of followup enough for outcomes to occur (n = 44) 439,453,456,469,487,492,501,522,548,563,574,583,599,605,614,619,624,776,820,873,874a624b105,141,142,422,630,663,669,670,688,695,708,833,855,861,877,949,950,969,994a950b936,973a
Cohort studies reporting adequate followup of cohorts (n = 29) 141,439,469,487,501,522,548,599,605,614,619,630,669,670,708,855,857,861,873,874,877,921,949,950,969,994a950b936,973a
Cohort studies that reported source of funding (n = 41) 161,200,201,385,399,416,422,439,453,456,486,492,498,555,585,605,607,644,734,745,755,757,760,776,788,792,807,833,874,877,886,909,912,949,960,967,989,997,1003,1008,1009
Cross sectional studies—NOS scaleCross sectional studies describing representative samples of the target population (n = 62) 951a951b388,441,443,446,454,470,473,481,495497,506,529,534,535,551,552,978a552b432,560,565,568,570,582,591,628,632,646,648,649,660,661,701,717,729,740,744,748,778,865,869,876,879,880,887,888,890,892,896,899,901,902,905,908,924,933,941,976,990
Cross sectional studies describing that comparison groups were drawn from the same community as the study group (n = 24) 951a951b388,390,441,446,454,481,497,570,582,591,628,646,648,660,701,722,737,740,778,849,899,924
Cross sectional studies that reported reliable methods for ascertainment of exposure (n = 0)
Cross sectional studies that adjusted for important confounding factors in the design or analysis (n = 63) 146,951a951b388,390,438,441,443,446,470,473,495497,506,511,529,546,551,552,795,798,980a552b412,560,568,570,591,638,640,641,646,661,664,667,701,717,722,732,735,740,743,744,748,778,849,865,876,880,884,887,888,890,892,899,901,905,911,924,933,976,990
Cross sectional studies that reported reliable methods for outcome assessment (n = 62) 146,451,465,509,798,978,980,1010a513,551,552a552b432,565,632,636,640,641,646,648,664,667,694,701,717,718,729,732,735,737,740,743,744,842,859,869,876,879881,884,892,893,896,898,899,901903,905,908,911,918,937,941,957,968,975,976,990,1000,1004
Cross sectional studies that reported source of funding (n = 27) 388,432,438,473,511,632,636,641,646,649,704,744,778,798,876,879,880,888,893,896,901903,905,908,957,1010

NOS = Newcastle-Ottawa scales

From: Appendix G. Summary Tables for Topic II

Cover of Meditation Practices for Health
Meditation Practices for Health: State of the Research.
Evidence Reports/Technology Assessments, No. 155.
Ospina MB, Bond K, Karkhaneh M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.